What is the appropriate management for a patient whose blood glucose was 404 mg/dL before receiving insulin?

Management of Blood Glucose 404 mg/dL Before Insulin

For a hospitalized patient with blood glucose of 404 mg/dL who has already received insulin, continue scheduled subcutaneous basal-bolus insulin therapy with a target range of 140-180 mg/dL, monitoring blood glucose every 4-6 hours and adjusting doses based on response. 1

Initial Assessment and Insulin Dosing

Since the patient's glucose was 404 mg/dL before insulin administration, this represents severe hyperglycemia requiring immediate insulin therapy. The appropriate starting total daily dose (TDD) calculation is:

• 0.5 units/kg/day for blood glucose 201-400 mg/dL 1
• Distribute as 50% basal insulin (once or twice daily) and 50% nutritional/prandial insulin (divided before meals) 1

For example, a 70 kg patient would receive approximately 35 units total daily: 17-18 units as basal insulin (glargine or detemir once daily, or NPH twice daily) plus 5-6 units of rapid-acting insulin before each meal.

Ongoing Management Strategy

Blood Glucose Monitoring

• Check blood glucose every 4-6 hours if NPO (nothing by mouth) 2
• Check before each meal and at bedtime if eating 1
• Target range: 140-180 mg/dL for non-critically ill hospitalized patients 1, 3

Correction Insulin Dosing

Add supplemental rapid-acting insulin based on current glucose levels using a correction scale. For a patient with glucose previously at 404 mg/dL (indicating insulin resistance), use the "insulin-resistant" column 1:

Blood Glucose	Correction Dose
301-350 mg/dL	14 units
351-400 mg/dL	16 units
≥400 mg/dL	18 units

Critical caveat: If the patient is elderly, has renal impairment (GFR <60), or is NPO, start with the "insulin-sensitive" column (lower doses) to prevent hypoglycemia 1.

Adjusting the Insulin Regimen

Daily Dose Adjustments

• If glucose remains >180 mg/dL despite current regimen, increase total daily dose by 10-20% 4
• If hypoglycemia occurs (<70 mg/dL), decrease corresponding insulin dose by 10-20% 4
• Reassess adequacy at every clinical encounter 4

Special Considerations for High Initial Glucose

With an initial glucose of 404 mg/dL, consider:

1. Rule out DKA/HHS: Check for ketones, electrolytes, and acid-base status, especially if the patient has type 1 diabetes or symptoms of nausea, vomiting, or altered mental status 2

2. Assess precipitating factors:

   • Infection or sepsis
   • Steroid use (requires NPH insulin timed with steroid dosing) 5, 2
   • Missed insulin doses
   • New diagnosis of diabetes 1

3. Avoid sliding scale insulin alone: This outdated approach results in unacceptable hyperglycemia and hypoglycemia 1, 6. Always use scheduled basal insulin with correction doses.

Transition Planning

Once glucose stabilizes in target range:

• Continue basal insulin even if patient becomes NPO 1
• Hold prandial insulin if meals are missed, but maintain basal coverage 1
• For patients with well-controlled type 1 diabetes made NPO, give 80-90% of usual basal dose 1
• For uncontrolled patients (glucose >200 mg/dL), full basal dose is safe 1

Common Pitfalls to Avoid

1. Never discontinue all insulin when patient becomes NPO—this causes rebound hyperglycemia and potential DKA in type 1 diabetes 1

2. Don't use correction insulin alone without basal coverage—this reactive approach leads to poor control 6, 7

3. Avoid mixing LEVEMIR (detemir) with other insulins—this alters pharmacokinetics and reduces efficacy by up to 40% 8

4. Watch for hypoglycemia risk factors: renal impairment, reduced oral intake, elderly age, or sudden reduction in steroid doses 9, 8

5. Don't target glucose <140 mg/dL in hospitalized patients—stricter targets increase hypoglycemia without improving outcomes 2